期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
难治性青光眼患者经巩膜810睫状体光凝术后眼压变化及影响因素
1
作者 庞彦利 陈瑞强 汪雪婷 《海南医学》 CAS 2024年第8期1106-1110,共5页
目的探讨难治性青光眼患者经巩膜810睫状体光凝术后眼压变化及其影响因素。方法选取2018年7月到2022年12月濮阳市第二人民医院收治的181例难治性青光眼患者作为研究对象。所有患者均接受经巩膜810睫状体光凝术治疗。比较所有患者术前、... 目的探讨难治性青光眼患者经巩膜810睫状体光凝术后眼压变化及其影响因素。方法选取2018年7月到2022年12月濮阳市第二人民医院收治的181例难治性青光眼患者作为研究对象。所有患者均接受经巩膜810睫状体光凝术治疗。比较所有患者术前、术后1 d、1周、1个月、3个月、6个月的眼压。根据患者术后6个月的眼压分为眼压控制良好组(眼压6~21 mmHg)151例和眼压控制不佳组(眼压>21 mmHg或<6 mmHg)30例。收集两组患者的相关临床资料,采用单因素分析及多因素Logistic回归分析方程分析影响患者术后眼压的因素。结果患者术后1 d、1周、1个月、3个月、6个月的眼压分别为(28.79±12.44)mmHg、(21.79±11.30)mmHg、(18.62±7.81)mmHg、(16.38±7.45)mmHg、(13.88±7.41)mmHg,均较术前眼压(47.06±12.29)mmHg降低,差异均有统计学意义(P<0.05);两组患者术后1 d、1周、1个月、3个月的眼压比较差异均无统计学意义(P>0.05),但眼压控制良好组患者术后6个月的眼压为(13.16±4.45)mmHg,明显低于眼压控制不佳组的(17.50±14.91)mmHg,差异有统计学意义(P<0.05);单因素分析结果显示,两组患儿的年龄、性别、术眼、吸烟史、饮酒史、青光眼家族史比较差异均无统计学意义(P>0.05),但眼压控制良好组患者的高血压史、糖尿病史、高脂血症史占比明显低于眼压控制不良组,差异均有统计学意义(P<0.05);多因素Logistic回归分析结果显示,高血压史、糖尿病史、高脂血症史均是难治性青光眼患者经巩膜810睫状体光凝术后眼压的影响因素(P<0.05)。结论经巩膜810睫状体光凝术治疗可降低难治性青光眼患者眼压,高血压史、糖尿病史、高脂血症史均是影响患者术后眼压的因素。 展开更多
关键词 难治性青光眼 经巩膜810睫状体光凝术 眼压 影响因素
下载PDF
广西大肠杆菌对多种抗菌药物的耐药率及部分耐药基因检测 被引量:3
2
作者 罗远燕 陈心瑜 +6 位作者 陈鑫 杜倩笙 庞燕丽 劳承连 李崇 王莉贞 司红彬 《中国兽医杂志》 CAS 北大核心 2021年第1期72-76,共5页
为研究广西地区大肠杆菌对常用抗菌药物的耐药情况及耐药基因检出情况,采用2倍微量稀释法对实验室分离鉴定后甘油保藏的113株大肠杆菌进行头孢曲松钠、氟苯尼考等13种常见抗菌药物的药敏试验;筛选出42株对3种或3种以上药物最小抑菌浓度(... 为研究广西地区大肠杆菌对常用抗菌药物的耐药情况及耐药基因检出情况,采用2倍微量稀释法对实验室分离鉴定后甘油保藏的113株大肠杆菌进行头孢曲松钠、氟苯尼考等13种常见抗菌药物的药敏试验;筛选出42株对3种或3种以上药物最小抑菌浓度(MIC)≥3200μg/mL的大肠杆菌,扩增bla TEM基因、bla CTX-M-9基因、sul 2基因。结果显示,细菌对头孢噻呋钠、氟苯尼考、磺胺间甲氧嘧啶、阿莫西林、环丙沙星、头孢噻肟钠、头孢曲松钠、左旋氧氟沙星、加替沙星的耐药率较高,分别为99.1%、99.1%、93.5%、92.9%、91.1%、89.9%、73.4%、72.5%、69.4%;对头孢他啶、磷霉素、阿米卡星、美罗培南的耐药率为56.6%、50.5%、32.7%、3.5%。在42株菌中,bla TEM基因、bla CTX-M-9基因、sul 2基因阳性率为19.0%、38.1%、45.2%。表明广西地区大肠杆菌对常见抗菌药物耐药情况趋于严重,耐药率呈升高趋势,以产超广谱β-内酰胺酶(ESBLs)大肠杆菌耐药基因及磺胺类sul 2耐药基因检出率偏高,为临床合理用药及兽医临床大肠杆菌耐药性研究提供理论依据。 展开更多
关键词 大肠杆菌 耐药性 耐药基因 抗菌药物
下载PDF
Surgical management of intrahepatic vessels in children with stage III/IV hepatoblastoma
3
作者 pang yan-li ZHAO Wei +7 位作者 YANG He-ying LIU Qiu-liang ZHANG Da QIN Pan YUE Ming WANG Lei ZHANG Jun-jie WANG Jia-xiang 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第11期2134-2138,共5页
Background Hepatoblastoma (HB) is a rare childhood tumor. We investigated the effect of intraoperative management of the intrahepatic major vessels in children with HB. Methods Between April 2005 and August 2012, su... Background Hepatoblastoma (HB) is a rare childhood tumor. We investigated the effect of intraoperative management of the intrahepatic major vessels in children with HB. Methods Between April 2005 and August 2012, surgical resection was performed on 50 children with hepatoblastoma. These children were divided into a vessel-ligation group (n=20) and a vessel-repair group (n=30). In the vessel-ligation group, the intrahepatic major vessels were ligated and removed together with the tumor and the affected liver lobe/liver parenchyma. In the vessel-repair group, the affected intrahepatic major vessels were dissected and preserved as much as possible and the normal liver lobe/liver parenchyma and blood supply from these vessels were also preserved. The outcomes were analyzed by postoperative follow-up. Results In the vessel-ligation group, two patients gave up surgery, six patients underwent palliative resection, and 12 patients underwent en bloc resection; four patients died of liver failure and eight patients fully recovered and were discharged. In the vessel-repair group, all 30 patients underwent en bloc resection and were discharged after satisfactory healing. After a follow-up time of 5-36 months (median: 20 months), two patient in the vessel-ligation group survived and 22 patients in the vessel-repair group survived. Conclusions Patients with HB can be successfully treated by tumor resection with vascular repair. This method prevents postoperative liver failure, ensures patient safety during the perioperative period, and allows for early chemotherapy. 展开更多
关键词 HEPATOBLASTOMA liver failure intraoperative management vessel ligation vessel repair
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部